L&C BIO Co.,LTD (KOSDAQ:290650)

L&C BIO Co.,LTD Revenue

L&C BIO Co.,LTD had revenue of 38.79B KRW in the quarter ending June 30, 2026, with 88.45% growth. This brings the company's total for the last twelve months to 116.30B, up 53.20% year-over-year. In the year 2025, L&C BIO Co.,LTD had annual revenue of 85.48B with 18.66% growth. That makes L&C BIO Co.,LTD the 23,646th largest company in the world by revenue and 1,347th in South Korea.

• Revenue (ttm): 116.30B
• Revenue Growth: +53.20%
• P/S Ratio: 13.91
• Revenue / Employee: 635.54M
• Employees: 183
• Market Cap: 1.62T

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 79.50B 93.0%
• Export 5.98B 7.0%

Fiscal year ended Dec 31, 2025 See the full L&C BIO Co.,LTD breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	85.48B	13.44B	18.66%
Dec 31, 2024	72.03B	6.11B	9.26%
Dec 31, 2023	65.93B	13.35B	25.40%
Dec 31, 2022	52.57B	6.90B	15.10%
Dec 31, 2021	45.68B	12.70B	38.53%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error